Resistance to anti-cancer therapeutics targeting receptor tyrosine kinases and downstream pathways
Éditeur :
Springer Nature Switzerland AG
ISBN :
9783030098179
Date de publication :
2 févr. 2019
Dimensions :
23,5 x 15,5 cm
Langue :
Anglais
Pays d'origine :
Suisse
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression.